DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia

Blood

Volumn 111, Issue 4, 2008, Pages 2374-2377

  Glasow, Annegret ^a,b   Barrett, Angela ^a   Petrie, Kevin ^a   Gupta, Rajeev ^c   Boix Chornet, Manuel ^a   Zhou, Da Cheng ^d   Grimwade, David ^e   Gallagher, Robert ^d   Von Lindern, Marieke ^f   Waxman, Samuel ^g   Enver, Tariq ^c   Hildebrandt, Guido ^b   Zelent, Arthur ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ALBERT EINSTEIN CANCER CENTER   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; LYSINE; RETINOIC ACID RECEPTOR ALPHA;

5' UNTRANSLATED REGION; ACETYLATION; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE LOSS; HUMAN; HUMAN CELL; METHYLATION; MYELOID PROGENITOR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 41349083560     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-05-088344     Document Type: Article

References (29)

1. Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107:2099-2107.
2. Zelent A, Guidez F, Melnick A, Waxman S, Licht JD. Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene. 2001;20:7186-7203.
3. Warrell RP, Jr., de The H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med. 1993;329:177-189.
4. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000;14:121-141.
5. Zhu J, Gianni M, Kopf E, et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. Proc Natl Acad Sci U S A. 1999;96:14807-14812.
6. Lallemand-Breitenbach V, Zhu J, Kogan S, Chen Z, de The H. Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia. Nat Rev Cancer. 2005;5:821-827.
7. Glasow A, Prodromou N, Xu K, von Lindern M, Zelent A. Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways. Blood. 2005;105:341-349.
8. Zhu J, Heyworth CM, Glasow A, et al. Lineage restriction of the RARalpha gene expression in myeloid differentiation. Blood. 2001;98:2563-2567.
9. Purton LE, Dworkin S, Olsen GH, et al. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med. 2006;203:1283-1293.
10. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia. 2002;16:1896-1905.
11. Balmer JE, Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res. 2002;43:1773-1808.
12. Yamanaka R, Barlow C, Lekstrom-Himes J, et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A. 1997;94:13187-13192.
13. White JA, Beckett-Jones B, Guo YD, et al. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem. 1997;272:18538-18541.
14. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683-692.
15. Epping MT, Wang L, Edel MJ, Carlee L, Hernandez M, Bernards R. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell. 2005;122:835-847.
16. Dupont JM, Tost J, Jammes H, Gut IG. De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem. 2004;333:119-127.
17. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994;22:2990-2997.
18. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18:1427-1431.
19. Musri MM, Corominola H, Casamitjana R, Gomis R, Parrizas M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem. 2006;281:17180-17188.
20. Yan C, Boyd DD. Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol Cell Biol. 2006;26:6357-6371.
21. Fazi F, Zardo G, Gelmetti V, et al. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood. 2007;109:4432-4440.
22. Di Croce L, Raker VA, Corsaro M, et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science. 2002;295:1079-1082.
23. Villa R, Morey L, Raker VA, et al. The methyl-CpG binding protein MBD1 is required for PML-RARalpha function. Proc Natl Acad Sci U S A. 2006;103:1400-1405.
24. Chim CS, Wong SY, Pang A, et al. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Leukemia. 2005;19:2241-2246.
25. Rethmeier A, Aggerholm A, Olesen LH, et al. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts. Br J Haematol. 2006;133:276-283.
26. Esteller M, Fraga MF, Paz MF, et al. Cancer epigenetics and methylation. Science. 2002;297:1807-1808.
27. Tabe Y, Konopleva M, Kondo Y, et al. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter. Ann Hematol. 2006;85:689-704.
28. Luo J, Pasceri P, Conlon RA, Rossant J, Giguere V. Mice lacking all isoforms of retinoic acid receptor beta develop normally and are susceptible to the teratogenic effects of retinoic acid. Mech Dev. 1995;53:61-71.
29. Oki Y, Aoki E, Issa JP. Decitabine: bedside to bench. Crit Rev Oncol Hematol. 2007;61:140-152.